Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2019-02-15 17:45 |
AMOEBA announces the issuance of the second tranche of 26 bonds convertible int…
|
English | PDF • 151.8 KB | ||
| 2019-02-12 17:57 |
AMOEBA annonce que l’Autriche a accepte´ d’e^tre l’E´tat membre rapporteur pour…
|
French | PDF • 169.0 KB | ||
| 2019-02-12 17:57 |
AMOEBA announces that Austria has agreed to be the Rapporteur Member State to s…
|
English | PDF • 136.7 KB | ||
| 2019-02-11 17:45 |
AMOEBA annonce une avancée scientifique majeure sur la formulation de son amibe…
|
French | PDF • 133.1 KB | ||
| 2019-02-11 17:40 |
AMOEBA annonce une avancée scientifique majeure sur la formulation de son amibe…
|
French | PDF • 133.1 KB | ||
| 2019-02-11 17:40 |
AMOEBA announces a major scientific advance on the formulation of its amoeba Wi…
|
English | PDF • 107.3 KB | ||
| 2019-01-16 17:40 |
Amoeba annonce l'émission de 26 obligations convertibles en actions dans le cad…
|
French | PDF • 150.7 KB | ||
| 2019-01-16 17:40 |
Amoeba announces the issuance of 26 bonds convertible into shares as part of it…
|
English | PDF • 145.3 KB | ||
| 2019-01-03 17:40 |
Bilan semestriel du contrat de liquidité
|
French | PDF • 130.4 KB | ||
| 2019-01-03 17:40 |
Half-year review of the liquidity contract
|
English | PDF • 126.0 KB | ||
| 2018-12-28 17:45 |
ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 14 JANVIER 2019 MODALITES DE …
|
French | PDF • 145.1 KB | ||
| 2018-12-28 17:45 |
ORDINARY AND EXTRAORDINARY ANNUAL GENERAL MEETING TO BE HELD ON 14th JANUARY 20…
|
English | PDF • 128.9 KB | ||
| 2018-12-20 18:32 |
AMOEBA annonce dans le cadre de son financement par voie d’émission d’obligatio…
|
French | PDF • 539.2 KB | ||
| 2018-12-20 18:32 |
AMOEBA announces the approval by the AMF of the transaction note relating to th…
|
English | PDF • 531.0 KB | ||
| 2018-12-03 17:45 |
AMOEBA annonce la signature d’un avenant au contrat d’émission d’obligations co…
|
French | PDF • 196.8 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
